Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Morphomer-based Alpha-synuclein PET Tracers

NCT05067192 is registered in ClinicalTrials.gov with Skane University Hospital as lead sponsor.

NCT NCT05067192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05067192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Morphomer-based Alpha-synuclein PET Tracers
Lead sponsor
Skane University Hospital
Phase
Observational
Overall status
Completed
Start date
July 15, 2021
Completion date
September 1, 2021
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corticobasal degeneration, dementia with lewy bodies, multiple system atrophy, parkinson disease, progressive supranuclear palsy